2025

Osmanska, J. et al. (2025) Cardiovascular magnetic resonance-estimated pulmonary capillary wedge pressure, congestion markers, and effect of empagliflozin in patients with heart failure with reduced ejection fraction and dysglycaemia (SUGAR-DM-HF). European Journal of Heart Failure, (doi: 10.1002/ejhf.3570) (PMID:39792133) (Early Online Publication)

2024

Osmanska, J., Petrie, M. C. , Docherty, K. F. , Lee, M. M.Y. , McMurray, J. J.V. and Campbell, R. (2024) Subcutaneous furosemide in heart failure: a systematic review. European Heart Journal: Cardiovascular Pharmacotherapy, (doi: 10.1093/ehjcvp/pvae083) (Accepted for Publication)

Osmanska, J., Jackson, A. M., Simpson, J., Adamson, C., Doherty, D., Mamet, H., Moir, L., Walker, N. L., Hogg, D. and Simpson, M. (2024) Preconception counselling in women of reproductive age attending cardiology clinics in Scotland. Heart, 110(13), pp. 908-915. (doi: 10.1136/heartjnl-2023-323666) (PMID:38627021)

Curtain, J. P. et al. (2024) Measuring congestion with a non-invasive monitoring device in heart failure and haemodialysis: CONGEST-HF. European Journal of Heart Failure, 26(6), pp. 1383-1392. (doi: 10.1002/ejhf.3290) (PMID:38741283)

Osmanska, J. et al. (2024) A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studies. European Heart Journal: Cardiovascular Pharmacotherapy, 10, pp. 35-44. (doi: 10.1093/ehjcvp/pvad073) (PMID:37804170) (PMCID:PMC10766906)

2023

Connelly, P. , Osmanska, J., Lee, M. M.Y. , Delles, C. , McEntegart, M. B. and Byrne, J. (2023) A case report of myocardial infarction in a young transgender man with testosterone therapy? raising awareness on healthcare issues in the transgender community and a call for further research. European Heart Journal: Case Reports, 7(12), ytad562. (doi: 10.1093/ehjcr/ytad562) (PMID:38093823) (PMCID:PMC10716680)

Yeoh, S. E. et al. (2023) Dapagliflozin versus metolazone in heart failure resistant to loop diuretics. European Heart Journal, 44(31), pp. 2966-2977. (doi: 10.1093/eurheartj/ehad341) (PMID:37210742)

Docherty, K. F. et al. (2023) Association of carbohydrate antigen 125 on the response to dapagliflozin in patients with heart failure. Journal of the American College of Cardiology, 82(2), pp. 142-157. (doi: 10.1016/j.jacc.2023.05.011) (PMID:37407113)

2020

Hawkins, N. M., Osmanska, J. and Petrie, M. C. (2020) Implantable cardioverter-defibrillators and survival - the fine line between efficacy concerns and ageism. European Journal of Heart Failure, 22(5), pp. 868-870. (doi: 10.1002/ejhf.1803) (PMID:32227573)

2019

Osmanska, J. and Jhund, P. S. (2019) Contemporary management of heart failure in the elderly. Drugs and Aging, 36(2), pp. 137-146. (doi: 10.1007/s40266-018-0625-4) (PMID:30535931)

2018

Osmanska, J., Hawkins, N. M., Toma, M., Ignaszewski, A. and Virani, S. A. (2018) Eligibility for cardiac resynchronization therapy in patients hospitalized with heart failure. ESC Heart Failure, 5(4), pp. 668-674. (doi: 10.1002/ehf2.12297) (PMID:29938922) (PMCID:PMC6073034)

Articles

Osmanska, J. et al. (2025) Cardiovascular magnetic resonance-estimated pulmonary capillary wedge pressure, congestion markers, and effect of empagliflozin in patients with heart failure with reduced ejection fraction and dysglycaemia (SUGAR-DM-HF). European Journal of Heart Failure, (doi: 10.1002/ejhf.3570) (PMID:39792133) (Early Online Publication)

Osmanska, J., Petrie, M. C. , Docherty, K. F. , Lee, M. M.Y. , McMurray, J. J.V. and Campbell, R. (2024) Subcutaneous furosemide in heart failure: a systematic review. European Heart Journal: Cardiovascular Pharmacotherapy, (doi: 10.1093/ehjcvp/pvae083) (Accepted for Publication)

Osmanska, J., Jackson, A. M., Simpson, J., Adamson, C., Doherty, D., Mamet, H., Moir, L., Walker, N. L., Hogg, D. and Simpson, M. (2024) Preconception counselling in women of reproductive age attending cardiology clinics in Scotland. Heart, 110(13), pp. 908-915. (doi: 10.1136/heartjnl-2023-323666) (PMID:38627021)

Curtain, J. P. et al. (2024) Measuring congestion with a non-invasive monitoring device in heart failure and haemodialysis: CONGEST-HF. European Journal of Heart Failure, 26(6), pp. 1383-1392. (doi: 10.1002/ejhf.3290) (PMID:38741283)

Osmanska, J. et al. (2024) A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studies. European Heart Journal: Cardiovascular Pharmacotherapy, 10, pp. 35-44. (doi: 10.1093/ehjcvp/pvad073) (PMID:37804170) (PMCID:PMC10766906)

Connelly, P. , Osmanska, J., Lee, M. M.Y. , Delles, C. , McEntegart, M. B. and Byrne, J. (2023) A case report of myocardial infarction in a young transgender man with testosterone therapy? raising awareness on healthcare issues in the transgender community and a call for further research. European Heart Journal: Case Reports, 7(12), ytad562. (doi: 10.1093/ehjcr/ytad562) (PMID:38093823) (PMCID:PMC10716680)

Yeoh, S. E. et al. (2023) Dapagliflozin versus metolazone in heart failure resistant to loop diuretics. European Heart Journal, 44(31), pp. 2966-2977. (doi: 10.1093/eurheartj/ehad341) (PMID:37210742)

Docherty, K. F. et al. (2023) Association of carbohydrate antigen 125 on the response to dapagliflozin in patients with heart failure. Journal of the American College of Cardiology, 82(2), pp. 142-157. (doi: 10.1016/j.jacc.2023.05.011) (PMID:37407113)

Hawkins, N. M., Osmanska, J. and Petrie, M. C. (2020) Implantable cardioverter-defibrillators and survival - the fine line between efficacy concerns and ageism. European Journal of Heart Failure, 22(5), pp. 868-870. (doi: 10.1002/ejhf.1803) (PMID:32227573)

Osmanska, J. and Jhund, P. S. (2019) Contemporary management of heart failure in the elderly. Drugs and Aging, 36(2), pp. 137-146. (doi: 10.1007/s40266-018-0625-4) (PMID:30535931)

Osmanska, J., Hawkins, N. M., Toma, M., Ignaszewski, A. and Virani, S. A. (2018) Eligibility for cardiac resynchronization therapy in patients hospitalized with heart failure. ESC Heart Failure, 5(4), pp. 668-674. (doi: 10.1002/ehf2.12297) (PMID:29938922) (PMCID:PMC6073034)